Session Information
Date: Monday, November 9, 2015
Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II
Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: New classification criteria for systemic sclerosis (SSc) were proposed by the ACR/EULAR in 2013, due to the low sensitivity of the 1980 ACR classification criteria for patients with early and limited SSc. This study aimed to evaluate the diagnostic performance of the new ACR/EULAR classification criteria for SSc in clinical practice including patients with early SSc.
Methods: Data from 178 patients with SSc, including 122 patients with established SSc (according to the 1980 ACR criteria) and 56 with early SSc (according to the LeRoy and Medsger 2001 criteria) were consecutively collected from September 2014 to May 2015 from a tertiary outpatient clinic. Data from 141 control patients with systemic lupus erythematosus, dermato/polymyositis, mixed connective tissue disease, undifferentiated connective tissue disease, Sjögren’s Syndrome, and primary Raynaud’s phenomenon were also collected. The sensitivity and specificity of the old and the new ACR/EULAR criteria were determined in several subgroups of patients with early SSc. The diagnostic performance of each item of the new criteria was also evaluated. The performance of the new ACR/EULAR criteria in discriminating SSc patients from controls was also evaluated by means of the Receiver Operating Characteristic (ROC) curve analysis. The best cut-off was determined based on the Youden’s index criteria.
Results: The new classification criteria showed a sensitivity of 77.6% and a specificity of 98.5% among the 178 patients with established and early SSc, and had a significantly higher sensitivity compared to the 1980 ACR criteria (p<0.001) (Table 1). Sixteen of 56 (28.5%) patients who were classified as patients with early SSc, were newly classified as SSc by the 2013 ACR/EULAR criteria. Sensitivity and specificity showed an excellent performance when only early SSc patients with both abnormal nailfold capillaroscopy and positive SSc-related antibodies were included (sensitivity of 90.0% and specificity of 98.5%) (Table 1). For this sample, the new classification criteria presented high accuracy in diagnosing SSc, with an area under the ROC curve (AUC) of 0.996 (95%CI 0.99-1.00; p<0.001). The best cut-off was a score of ≥8 (sensitivity of 96.1% and specificity of 97.9%). Abnormal nailfold capillaroscopy and sclerodactily were the individual items with the best performance (sensitivity of 93.3% and 78.2%; specificity of 83.6% and 100%, respectively).
Table 1.Sensitivity and specificity of the 1980 ACR criteria and the 2013 ACR/EULAR criteria in different subsets of patients
ACR 1980 | ACR/EULAR 2013 | |||
Sensitivity (95% CI) | Specificity (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | |
SSc patients (established and early SSc) (n=178) |
68% (0.60- 0.74) |
100% (0.97- 1.00) |
77.6% (0.71-0.83) |
98.5% (0.94-0.99) |
Established SSc and early SSc with abnormal nailfold capillaroscopy and positive SSc-related antibodies (n=152) |
80% (0.73-0.85) |
100% (0.97-1.00) |
90% (0.85-0.94) |
98.5% (0.94-0.99) |
Early SSc (n=56) |
0% (0-0.06) |
100% (0.97-1.00) |
28.5% (0.18-0.41) |
98.5% (0.94-0.99) |
Early SSc subsets |
||||
Raynaud’s phenomenon plus abnormal nailfold capillaroscopy and positive SSc-related antibodies (n=13) |
– | – |
53% (0.29-0.76) |
98.5% (0.94-0.99) |
Raynaud’s phenomenon plus abnormal nailfold capillaroscopy and negative SSc-related antibodies (n=31) |
– | – |
22% (0.11-0.39) ) |
98.5% (0.94-0.99) |
Raynaud’s phenomenon plus normal nailfold capillaroscopy and positive SSc-related antibodies (n=12) |
– | – |
16% (0.04-0.44) |
98.5% (0.94-0.99) |
Conclusion: The 2013 ACR/EULAR classification criteria for SSc presented higher sensitivity than the 1980 ACR criteria particularly among patients with early SSc. The cut-off of ≥ 8 for total score showed an excellent sensitivity with no loss of the specificity for the classification of patients with SSc in this cohort of patients, and may allow early intervention among patients with early disease.
To cite this abstract in AMA style:
Carvalho F, Camargo C, Fernandez B, Kayser C. Diagnostic Performance of the 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis: Results from a Brazilian Validation Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/diagnostic-performance-of-the-2013-acreular-classification-criteria-for-systemic-sclerosis-results-from-a-brazilian-validation-cohort/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-performance-of-the-2013-acreular-classification-criteria-for-systemic-sclerosis-results-from-a-brazilian-validation-cohort/